Prevention of various forms of metabolic myocardial necrosis by catatoxic steroids.
D000818:Animals; D009202:Cardiomyopathies / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D003900:Desoxycorticosterone / Q000627:therapeutic use; D004074:Digitoxin / Q000037:antagonists & inhibitors*; D004195:Disease Models, Animal; D005032:Ethylestrenol / Q000627:therapeutic use; D005260:Female; D005438:Fludrocortisone / Q000037:antagonists & inhibitors*; D009203:Myocardial Infarction / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D009336:Necrosis / Q000517:prevention & control; D009654:Norsteroids / Q000627:therapeutic use; D010074:Oxandrolone / Q000627:therapeutic use; D010472:Perchlorates / Q000037:antagonists & inhibitors*; D011239:Prednisolone / Q000627:therapeutic use; D011374:Progesterone / Q000627:therapeutic use; D051381:Rats; D012964:Sodium; D013148:Spironolactone / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use*; D014221:Triamcinolone / Q000627:therapeutic use
D009654:Norsteroids; D010472:Perchlorates; D013256:Steroids; D014221:Triamcinolone; D013148:Spironolactone; D003900:Desoxycorticosterone; D011374:Progesterone; D010074:Oxandrolone; D012964:Sodium; D011239:Prednisolone; D005032:Ethylestrenol; D004074:Digitoxin; D005438:Fludrocortisone